|
MechanismGABAA receptor positive allosteric modulators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date23 Jun 1972 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date01 Jan 1941 |
100 Clinical Results associated with AJENAT PHARMACEUTICALS LLC
0 Patents (Medical) associated with AJENAT PHARMACEUTICALS LLC
100 Deals associated with AJENAT PHARMACEUTICALS LLC
100 Translational Medicine associated with AJENAT PHARMACEUTICALS LLC